ribavirin has been researched along with Dermatoses in 28 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (7.14) | 18.2507 |
| 2000's | 13 (46.43) | 29.6817 |
| 2010's | 13 (46.43) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Campo-Cerecedo, F; Grueiro, MC; Monteagudo, B; Vilas-Sueiro, A | 1 |
| An, J; Deng, H; Feng, Y; Ji, F; Li, Z; Xiao, S; Zhang, Y | 1 |
| Chiang, CH; Lai, FJ | 1 |
| Waltschew, A | 1 |
| Ariaudo, A; Boglione, L; Carcieri, C; Cariti, G; Cusato, J; D'Avolio, A; De Nicolò, A; Di Perri, G; Favata, F; Mornese Pinna, S | 1 |
| Cotter, MA; Petersen, MJ; Squires, SM | 1 |
| Atluri, D; Iduru, S; Mullen, K; Veluru, C | 1 |
| Jordá, E; López, V; Molina, I; Monteagudo, C | 1 |
| Bourlière, M; Buggisch, P; Cacoub, P; Dupin, N; Dusheiko, G; Hézode, C; Lübbe, J; Picard, O; Pujol, R; Roujeau, JC; Segaert, S; Thio, B | 1 |
| Hézode, C | 1 |
| Forestier, N; Zeuzem, S | 1 |
| Bacon, BR; Khalid, O | 1 |
| Esteban, R; Shiffman, ML | 1 |
| Chayama, K; Hayashi, N; Kumada, H; Okanoue, T; Toyota, J; Tsubouchi, H | 1 |
| Gitlin, N | 1 |
| Rogers, CJ; Romagosa, R; Vincek, V | 1 |
| Chebli, JM; Gaburri, AK; Gaburri, PD; Martins Junior, EV | 1 |
| Ide, T; Kawaguchi, T; Kumashiro, R; Nagao, Y; Sata, M | 1 |
| Brito-Zerón, P; Cervera, R; Font, J; Mañá, J; Nardi, N; Ramos-Casals, M; Sánchez-Tapias, JM; Xaubet, A | 1 |
| Hurst, EA; Mauro, T | 1 |
| Alcántara-Torres, M; Artaza-Varasa, T; Gómez-Rodríguez, R; González de Frutos, C; Repiso-Ortega, A; Sánchez-Ruano, JJ | 1 |
| Calonje, E; Perera, GK | 1 |
| Delgado-Jimenez, Y; Fernandez-Herrera, J; Fraga, J; Garcia-Diez, A; Goiriz, R; Perez-Gala, S | 1 |
| Honsová, E; Sperl, J; Sticová, E | 1 |
| Dainichi, T; Enjoji, M; Gondo, H; Urabe, K | 1 |
| Chosidow, O; Descamps, V; Francès, C; Landry, J; Marinho, E; Ratziu, V | 1 |
| Faras, AJ; Gillett, CS; Gunther, R; Ostrow, RS | 1 |
| Janai, H | 1 |
9 review(s) available for ribavirin and Dermatoses
| Article | Year |
|---|---|
Cutaneous sarcoidosis developing after treatment with pegylated interferon and ribavirin: a new case and review of the literature.
Topics: Antiviral Agents; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Skin Diseases | 2011 |
Dermatological side effects of hepatitis C and its treatment: patient management in the era of direct-acting antivirals.
Topics: Antiviral Agents; Drug Eruptions; Hepatitis C; Humans; Interferon-alpha; Oligopeptides; Ribavirin; Skin Diseases | 2012 |
Boceprevir and telaprevir for the treatment of chronic hepatitis C: safety management in clinical practice.
Topics: Anemia; Antiviral Agents; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Withholding Treatment | 2012 |
Triple therapy with telaprevir: results in hepatitis C virus-genotype 1 infected relapsers and non-responders.
Topics: Adult; Aged; Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Treatment Failure; Treatment Outcome; Virus Replication; Young Adult | 2012 |
Triple therapy with boceprevir for HCV genotype 1 infection: phase III results in relapsers and nonresponders.
Topics: Anemia; Antiviral Agents; Clinical Trials, Phase III as Topic; Drug Substitution; Drug Therapy, Combination; Hepatitis C, Chronic; Humans; Interferon-alpha; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Recurrence; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Standard of Care; Treatment Failure | 2012 |
Triple therapy for HCV genotype 1 infection: telaprevir or boceprevir?
Topics: Algorithms; Anemia; Antiviral Agents; Clinical Protocols; Clinical Trials, Phase III as Topic; Drug Administration Schedule; Drug Therapy, Combination; Genotype; Hepatitis C, Chronic; Humans; Interferon-alpha; Interferons; Interleukins; Oligopeptides; Polyethylene Glycols; Proline; Recombinant Proteins; Ribavirin; Serine Proteinase Inhibitors; Skin Diseases; Time Factors; Viral Load | 2012 |
Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases.
Topics: Adult; Antiviral Agents; Female; Glucocorticoids; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prednisone; Ribavirin; Sarcoidosis; Skin Diseases | 2005 |
Sarcoidosis associated with pegylated interferon alfa and ribavirin treatment for chronic hepatitis C: a case report and review of the literature.
Topics: Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Risk Assessment; Sarcoidosis; Skin Diseases | 2005 |
Systemic sarcoidosis presenting in a tattooed man undergoing treatment for hepatitis C.
Topics: Antiviral Agents; Combined Modality Therapy; Hepatitis C, Chronic; Histiocytes; Humans; Immunotherapy; Interferon-alpha; Male; Middle Aged; Paint; Ribavirin; Sarcoidosis; Skin; Skin Diseases; Tattooing | 2006 |
1 trial(s) available for ribavirin and Dermatoses
| Article | Year |
|---|---|
Efficacy and safety of telaprevir, a new protease inhibitor, for difficult-to-treat patients with genotype 1 chronic hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Drug Therapy, Combination; Female; Genotype; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Japan; Male; Middle Aged; Oligopeptides; Polyethylene Glycols; Protease Inhibitors; Recombinant Proteins; Ribavirin; Skin Diseases; Treatment Outcome; Withholding Treatment | 2012 |
18 other study(ies) available for ribavirin and Dermatoses
| Article | Year |
|---|---|
Papular Sarcoidosis of the Knees Following Treatment with Interferon Alpha and Ribavirin in a Woman with Hepatitis C.
Topics: Antiviral Agents; Drug Eruptions; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Knee; Middle Aged; Ribavirin; Sarcoidosis; Skin Diseases | 2019 |
Predictive factors for adverse dermatological events during pegylated/interferon alpha and ribavirin treatment for hepatitis C.
Topics: Adult; Aged; Antiviral Agents; Female; Hepacivirus; Hepatitis C; Hepatitis C, Chronic; Humans; Interferon-alpha; Male; Middle Aged; Prognosis; Retrospective Studies; Ribavirin; Risk Factors; Skin Diseases; Treatment Outcome; Viral Load; Young Adult | 2014 |
Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C.
Topics: Aged; Antiviral Agents; Hepatitis C, Chronic; Humans; Injections; Interferon-alpha; Male; Ribavirin; Sarcoidosis; Sarcoidosis, Pulmonary; Skin Diseases | 2014 |
[Cutaneous sarcoidosis after treatment with interferon for hepatitis C: A not entirely rare but often overlooked reaction].
Topics: Aged; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Injections, Intravenous; Injections, Subcutaneous; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Skin; Skin Diseases | 2016 |
Role of simeprevir plasma concentrations in HCV treated patients with dermatological manifestations.
Topics: Adult; Antiviral Agents; Drug Monitoring; Drug Therapy, Combination; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Interferon-alpha; Logistic Models; Male; Middle Aged; Prospective Studies; Ribavirin; Simeprevir; Skin Diseases; Treatment Outcome; Viral Load | 2017 |
Pruritic papules limited to tattooed skin.
Topics: Adult; Hepatitis C, Chronic; Humans; Interferons; Male; Ribavirin; Sarcoidosis; Skin; Skin Diseases; Tattooing | 2009 |
A levitating tattoo in a hepatitis C patient on treatment.
Topics: Antiviral Agents; Biopsy, Needle; Drug Therapy, Combination; Follow-Up Studies; Hepatitis C, Chronic; Humans; Immunohistochemistry; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Pulmonary Disease, Chronic Obstructive; Recombinant Proteins; Ribavirin; Risk Assessment; Sarcoidosis; Skin Diseases; Steroids; Tattooing; Treatment Outcome | 2010 |
Manifestation of sarcoidosis during interferon and ribavirin therapy for chronic hepatitis C: a report of two cases.
Topics: Biopsy, Needle; Follow-Up Studies; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Risk Assessment; Sarcoidosis; Skin Diseases | 2002 |
Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Skin Diseases | 2004 |
Cutaneous vasculitis with undetectable cryoglobulinemia in chronic hepatitis C.
Topics: Antiviral Agents; Cryoglobulinemia; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; Middle Aged; Ribavirin; Skin Diseases; Vasculitis | 2004 |
Exacerbation of oral erosive lichen planus by combination of interferon and ribavirin therapy for chronic hepatitis C.
Topics: Aged; Hepacivirus; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Interferon-beta; Interferons; Leukoplakia; Lichen Planus; Lichen Planus, Oral; Male; Recombinant Proteins; Ribavirin; RNA, Viral; Skin Diseases; Steroids; Time Factors; Transaminases | 2005 |
[Cutaneopulmonary sarcoidosis during pegylated interferon plus ribavirin therapy].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Humans; Interferon alpha-2; Interferon-alpha; Male; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Sarcoidosis, Pulmonary; Skin Diseases | 2006 |
Cutaneous sarcoidosis limited to scars following pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Topics: Cicatrix; Diagnosis, Differential; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Recombinant Proteins; Ribavirin; Sarcoidosis; Skin Diseases | 2007 |
[Cutaneous sarcoidosis during pegylated interferon alpha and ribavirin treatment of chronic hepatitis C--a case report].
Topics: Adult; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Skin Diseases | 2007 |
[Cutaneous reactions induced by pegylated-interferon plus ribavirin combination therapy in a patient with chronic hepatitis C].
Topics: Aged; Anti-Allergic Agents; Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Skin Diseases | 2007 |
Facial cosmetic filler injections as possible target for systemic sarcoidosis in patients treated with interferon for chronic hepatitis C: two cases.
Topics: Antiviral Agents; Biocompatible Materials; Cosmetic Techniques; Female; Granuloma; Hepatitis C; Humans; Hyaluronic Acid; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Sarcoidosis; Sarcoidosis, Pulmonary; Silicones; Skin; Skin Diseases | 2008 |
Alopecia associated with ribavirin administration in rabbits.
Topics: Alopecia; Animals; Female; Hair; Rabbits; Ribavirin; Ribonucleosides; Skin Diseases; Warts | 1990 |
Adverse drug reactions: United States experience. I.
Topics: Bronchial Spasm; Humans; Infant; Infant, Newborn; Respiratory Syncytial Viruses; Respirovirus Infections; Retrospective Studies; Ribavirin; Skin Diseases; Surveys and Questionnaires; United States | 1990 |